Hereditary spherocytosis in neonates with hyperbilirubinemia

Pediatrics

Volumn 125, Issue 1, 2010, Pages 120-125

  Christensen, Robert D ^a,b   Henry, Erick ^a,c  

^a Intermountain Healthcare ^*  (United States)

^b McKay Dee Hospital Center   (United States)

^c Institute for Healthcare Delivery Research   (United States)

Author keywords

Hemolysis; Hereditary spherocytosis; Jaundice; Kernicterus; Neonate

Indexed keywords

BILIRUBIN; HEMOGLOBIN;

ARTICLE; CAREGIVER; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COOMBS TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; ERYTHROCYTE; FOLLOW UP; HEALTH CARE; HEMOGLOBIN DETERMINATION; HEREDITARY SPHEROCYTOSIS; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; MEDICAL RECORD; NEWBORN; PREVALENCE; PRIORITY JOURNAL;

BILIRUBIN; COMORBIDITY; CONFIDENCE INTERVALS; FEMALE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INCIDENCE; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SPHEROCYTOSIS, HEREDITARY; UNITED STATES;

EID: 74049158630     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-0864     Document Type: Article

References (27)

1. Gallager PG, Glader B. Hereditary spherocytosis, hereditary elliptocytosis, and other disorders associated with abnormalities of the erythrocyte membrane. In: Greer JP, Foerster J, Rodgers GM, et al, eds. Wintrobe's Clinical Hematology. 12th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:911-920
2. Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008;372(9647):1411-1426
3. Berardi A, Lugli L, Ferrari F, et al. Kernicterus associated with hereditary spherocytosis and UGT1A1 promoter polymorphism. Biol Neonate. 2006;90(4):243-246
4. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175(6):587-590
5. Michaels LA, Cohen AR, Zhao H, Raphael RI, Manno CS. Screening for hereditary spherocytosis by use of automated erythrocyte indexes. J Pediatr. 1997;130(6):957-960
6. Akar N, Gokce H. Red blood cell indexes in patients with hereditary spherocytosis and beta-thalassemia combination. Pediatr Hematol Oncol. 2002;19(8):569-573
7. Eberie ES, Sciuccati G, Bonduel M, Diaz L, Staciuk R, Torres AF. Erythrocyte indexes in hereditary spherocytosis [in Spanish]. Medicina (B Aires). 2007;67(6 pt 2):698-700
8. Alter BP, Goldberg JD, Berkowitz RL. Red cell size heterogeneity during ontogeny. Am J Pediatr Hematol Oncol. 1988;10(4):279-282
9. Qurtom HA, al-Saleh QU, Lubani MM, et al. The value of red cell distribution width in the diagnosis of anaemia in children. Eur J Pediatr. 1989;148(8):745-748
10. Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics. 2006;117(5). Available at: www.pediatrics.org/cgi/content/full/117/5/e855
11. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103(1):6-14
12. Christensen RD, Jopling J, Henry E, Wiedmeier SE. The erythrocyte indices of neonates, defined using data from over 12,000 patients in a multihospital health care system. J Perinatol. 2008;28(1):24-28
13. Christensen RD, Henry E, Jopling J, Wiedmeier SE. The CBC: reference ranges for neonates. Semin Perinatol. 2009;33(1):3-11
14. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the Pilot USA kernicterus registry (1991 to 2004). J Perinatol. 2009;29(suppl 1):S25-S45
15. Bhutani VK, Johnson L. Synopsis report from the pilot USA kernicterus registry. J Perinatol. 2009;29(suppl 1):S4-S7
16. Bhutani VK, Johnson L. A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus. J Perinatol. 2009;29(suppl 1):S61-S67
17. Stevenson DK, Wong RJ, Hintz SR, Vreman HJ. The jaundiced newborn: understanding and managing transitional hyperbilirubinemia[ in Italian]. Minerva Pediatr. 2002;54(5):373-382
18. Stevenson DK, Wong RJ, DeSandre GH, Vreman HJ. A primer on neonatal jaundice. Adv Pediatr. 2004;51:263-288
19. Saada V, Cynober T, Brossard Y, et al. Incidence of hereditary spherocytosis in a population of jaundiced neonates. Pediatr Hematol Oncol. 2006;23(5):387-397
20. Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics. 2003;111(6 pt 1):1303-1311
21. Kaplan M, Hammerman C. The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective. J Perinatol. 2009;29(suppl 1):S46-S52
22. Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase-deficient neonates: a potential cause for concern in North America. Pediatrics. 2000;106(6):1478-1479
23. Kaplan M, Hammerman C, Vreman HJ, Wong RJ, Stevenson DK. Severe hemolysis with normal blood count in a glucose-6-phosphate dehydrogenase deficient neonate. J Perinatol. 2008;28(4):306-309
24. Wintrobe MM. A simple and accurate hematocrit. J Lab Clin Med. 1929;15:287-296
25. Zipursky A, Chinu C, Brown E, Brown EJ. The quantitation of spherocytes in ABO hemolytic disease. J Pediatr. 1979;94(6):965-967
26. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics. 2004;114(4):1138]. Pediatrics. 2004;114(1):297-316
27. Christensen RD, Eggert LD, Baer VL, Smith KN. Pyruvate kinase deficiency as a cause of extreme hyperbilirubinemia in neonates from a polygamist community. J Perinatol. 2010 (in press)